全静脉麻醉对头颈癌微血管重建患者术后肺部并发症的影响:一项随机临床试验
这项在台湾一家三级医院开展的前瞻性双臂随机临床试验纳入78例拟行游离皮瓣手术的头颈癌患者,比较丙泊酚全静脉麻醉(TIVA)与吸入麻醉(INH)对术后肺部并发症(PPCs)的影响。70例完成试验,TIVA组发生PPCs的风险较低(未校正比值比0.25,95%CI 0.08-0.80)。作者认为丙泊酚TIVA减少了游离皮瓣手术中PPCs的发生率,可能与更稳定的血流动力学表现和术中更低的液体总平衡有关。
要点
- 丙泊酚TIVA组术后肺部并发症风险低于INH组,未校正OR 0.25(95%CI 0.08-0.80)。
- 监测第3小时后TIVA组MAP较高、CI较低、SVRI较高,INH组各参数随时间波动更明显。
- 作者认为TIVA减少PPCs可能与更稳定的血流动力学和更低的术中液体总平衡有关。
核心结论
- 在这项随机临床试验中,使用丙泊酚TIVA降低了游离皮瓣手术患者术后肺部并发症的发生率。
- 作者认为这一发现可能与更稳定的血流动力学表现和整个手术过程中更低的液体总平衡有关。
研究设计与样本
- 前瞻性、双臂随机临床试验,在台湾一家三级医院开展。
- 纳入78例18岁及以上、美国麻醉医师学会体格状态分级1至3级、拟在全身麻醉下择期行游离皮瓣手术的患者。
- 试验于2017年10月开始,2019年10月完成,2022年1月完成分析。
- 患者随机分入TIVA组或INH组,所有患者均接受目标导向液体治疗,并在平均动脉压(MAP)低于75 mm Hg或较基线MAP下降10%时进行血流动力学管理。
- 共70例患者完成试验(65名男性[93%],5名女性[7%])。
主要发现
- TIVA组年龄中位数(IQR)为52.0(48-59)岁,INH组为57.0(46-64)岁。
- 两组人口学特征相似,仅TIVA组体重指数略低。
- TIVA组发生PPCs的风险较低(未校正比值比0.25;95%CI 0.08-0.80)。
- 监测第3小时后,TIVA组MAP显著较高、CI较低、SVRI较高。
- TIVA组各时间点每小时MAP、CI、SVRI和SVV相对稳定,INH组波动更明显;广义估计方程显示两组间血流动力学参数随时间变化的趋势无临床差异。
关键数值与推荐
- 主要结局为PPCs的复合终点。
- 次要结局为术中血流动力学指标差异,包括平均动脉压(MAP)、心脏指数(CI)、体循环血管阻力指数(SVRI)和每搏量变异度(SVV)。
- TIVA组发生PPCs的未校正比值比为0.25(95%CI 0.08-0.80)。
- 血流动力学管理触发条件为MAP低于75 mm Hg或较基线MAP下降10%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Free flap surgery is a lengthy procedure with massive tissue destruction and reconstruction, which makes postoperative pulmonary complications (PPCs) a noticeable issue among patients with head and neck cancer. Propofol-based total intravenous anesthesia (TIVA) has better survival outcomes than inhalational anesthesia (INH) in several types of cancer surgery. A previous retrospective study found that patients in the TIVA group had a lower PPC rate, which may be correlated with a lower intraoperative fluid requirement. We hypothesize that the protective effect remains among patients undergoing free flap surgery for head and neck cancer in a prospective and goal-directed fluid therapy setting. OBJECTIVE: To assess the effect of TIVA vs INH on PPCs in patients undergoing microvascular reconstruction for head and neck cancer. DESIGN, SETTING, AND PARTICIPANTS: This prospective, 2-arm, randomized clinical trial was conducted at a tertiary hospital in Taiwan; a total of 78 patients 18 years and older with American Society of Anesthesiologists physical status classification 1 to 3 who were scheduled for elective free flap surgery under general anesthesia were included. The trial started in October 2017, completed in October 2019, and finished analysis in January 2022. INTERVENTIONS: Patients were enrolled and randomized to the TIVA or INH group. All patients received goal-directed fluid therapy and hemodynamic management if they had a mean arterial pressure (MAP) below 75 mm Hg or a reduction of 10% from baseline MAP. MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of PPCs. The secondary outcomes were the differences in intraoperative hemodynamic values (mean arterial pressure, MAP; cardiac index, CI; systemic vascular resistance index, SVRI; and stroke volume variation, SVV). RESULTS: A total of 70 patients (65 men [93%]; 5 women [7%]) completed the trial; median (IQR) age was 52.0 (48-59) years in the TIVA group and 57.0 (46-64) years in the INH group. The demographic characteristics were similar between the 2 groups, except that patients in the TIVA group had a slightly lower body mass index. Patients in the TIVA group had a lower risk of developing PPCs (unadjusted odds ratio, 0.25; 95% CI, 0.08-0.80). The TIVA group had significantly higher MAP, lower CI, and higher SVRI than the INH group after the third hour of monitoring. The TIVA group showed a relatively stable hourly MAP, CI, SVRI, and SVV across time points, while the INH group showed a more varying pattern. The generalized estimating equation showed no clinical differences in the trend of hemodynamic parameters across time between groups. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, using propofol-based TIVA reduced the incidence of PPCs in free flap surgery. This finding may be related to more stable hemodynamic manifestations and a lower total balance of fluid throughout the surgery. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03263078.
引用
- Chang YT, Lai CS, Lu CT, et al. Effect of Total Intravenous Anesthesia on Postoperative Pulmonary Complications in Patients Undergoing Microvascular Reconstruction for Head and Neck Cancer: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 36107412. doi:10.1001/jamaoto.2022.2552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。